Research Paper Volume 16, Issue 8 pp 7249—7266

AAT resistance-related AC007405.2 and AL354989.1 as novel diagnostic and prognostic markers in prostate cancer


Figure 10. The effects of AL354989.1 and AC007405.2 on AAT resistance in LNCaP cells. The expression levels of AC007405.2 (A) and AL354989.1 (B) were increased with the treatment of ENZ, ARN and BIC, respectively. The drug sensitivity curves of siR-AC007405.2 and siR-AL354989.1 in LNCaP cells under ENZ (C, D), ARN (E, F) and BIC (G, H) treatment, separately.